Therefore, lower thyroid hormone levels, which may further allow decreased signal to THRβ, might induce cancer-specific RUNX2 overexpression and finally present microcalcification specific to PTC, and mixed calcification, which consists of accumulated and combined microcalcifications. Here, RUNX2 is linked to cancer.